자료유형  

 학위논문

Control Number  

0016933309

International Standard Book Number  

9798380388290

Dewey Decimal Classification Number  

574

Main Entry-Personal Name  

Izzo, Luke T.

Publication, Distribution, etc. (Imprint  

[S.l.] : University of Pennsylvania., 2023

Publication, Distribution, etc. (Imprint  

Ann Arbor : ProQuest Dissertations & Theses, 2023

Physical Description  

1 online resource(158 p.)

General Note  

Source: Dissertations Abstracts International, Volume: 85-03, Section: B.

General Note  

Advisor: Wellen, Kathryn E.

Dissertation Note  

Thesis (Ph.D.)--University of Pennsylvania, 2023.

Restrictions on Access Note  

This item must not be sold to any third party vendors.

Summary, Etc.  

요약Cellular metabolism is intricately regulated by substrate availability, enzymatic activity, and compartmentalization within subcellular localization. It is also highly flexible, with cells demonstrating the ability to shift between metabolic pathways to maintain their function. Aberrant metabolic processes are linked to numerous diseases including obesity, diabetes, and cancer and these diseases often shows shifts from traditional homeostatic metabolism to alternative metabolic processes. Understanding the regulation of and flexibility in critical metabolic pathways is required for efficacious targeting of such pathways in disease states. The metabolite acetyl-CoA is involved in multiple metabolic pathways that are altered in disease. Acetyl-CoA metabolism is regulated, in part, by the subcellular localization of the enzymes that perform is synthesis and utilization. Nuclear-cytosolic acetyl-CoA is used for lipid synthesis and acetylation, processes that are often dysregulated in cancer. For this reason, the enzymes that produce it are attractive therapeutic targets, but flexibility in acetyl-CoA metabolism poses a problem for inhibiting these enzymes. A complete understanding of nuclear-cytosolic acetyl-CoA metabolism in order to identify proper strategies for targeting this pathway. Therefore, we utilize an approach to genetically ablate the known nuclear-cytosolic acetyl-CoA producers, ATP-citrate lyase (ACLY) and acyl-CoA synthetase short chain family member 2 (ACSS2), to probe alternate compensatory pathways and asses combinatorial treatments in a hepatocellular carcinoma model. We identify the acetylcarnitine shuttle as a previously uncharacterized link between mitochondria and nuclear-cytosolic acetyl-CoA that can regulate de novo lipogenesis and gene expression through histone acetylation. Moreover, we identify two potential nutrient conditions that may synergize with targeting of nuclear-cytosolic acetyl-CoA metabolism using genetic loss of ACLY in vivo and in vitro. Together, these findings have expanded our understanding of cellular acetyl-CoA metabolism and shed light on the possibility of successfully targeting these pathways in HCC.

Subject Added Entry-Topical Term  

Molecular biology.

Subject Added Entry-Topical Term  

Cellular biology.

Subject Added Entry-Topical Term  

Biochemistry.

Subject Added Entry-Topical Term  

Genetics.

Index Term-Uncontrolled  

Acetyl-CoA

Index Term-Uncontrolled  

Sacetylcarnitine shuttle

Index Term-Uncontrolled  

Cellular metabolism

Index Term-Uncontrolled  

Gene expression

Index Term-Uncontrolled  

Metabolic processes

Added Entry-Corporate Name  

University of Pennsylvania Cell and Molecular Biology

Host Item Entry  

Dissertations Abstracts International. 85-03B.

Host Item Entry  

Dissertation Abstract International

Electronic Location and Access  

로그인을 한후 보실 수 있는 자료입니다.

Control Number  

joongbu:639668